Clinical trial
Comparison of Oral Molecules Preventing Relapses in Multiple Sclerosis
NCT03302442
Study timeline
Study start (actual)2017-05-01Date precision: day
Registry last updated2017-10-05
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Relapsing-remitting Multiple Sclerosisunresolved
Interventions
Sponsors & collaborators
Nantes University Hospitallead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03302442 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.